Replies to post #27982 on Marker Therapeutics Inc (MRKR)

[poods]

Agree. I hope the CEO goes with a synergistic partnership at this juncture. The PC data may not have impressed the street, but a BP may bite based on the unexpected CR and the correlative immune response data, which was quite impressive.

[HANUMAN]

I think their strategy is already in play...knocking down the SP by nearly 50%, thereby making a buyout offer of $10-12/share seem generous.